{"id":2824,"date":"2021-11-30T10:03:49","date_gmt":"2021-11-30T09:03:49","guid":{"rendered":"https:\/\/wp.idlbiotech.com\/?page_id=2824"},"modified":"2026-02-24T14:40:01","modified_gmt":"2026-02-24T13:40:01","slug":"styrelsen","status":"publish","type":"page","link":"https:\/\/idldiagnostics.com\/sv\/investerare\/foretagsstyrning\/styrelsen\/","title":{"rendered":"Styrelsen"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;88f366a5-bf49-48d9-a338-ab22706b73e7&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;0px||0px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; custom_padding=&#8221;||||false|false&#8221; custom_padding_tablet=&#8221;10px||||false|false&#8221; custom_padding_phone=&#8221;0px||||false|false&#8221; custom_padding_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;][dipi_breadcrumbs _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; max_width=&#8221;800px&#8221; global_colors_info=&#8221;{}&#8221;][\/dipi_breadcrumbs][et_pb_divider color=&#8221;#EEEEEE&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; max_width=&#8221;800px&#8221; min_height=&#8221;1px&#8221; height=&#8221;20px&#8221; custom_margin=&#8221;||3px|||&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_divider][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;8738c908-7375-4c6c-99a7-9f91f8a3c099&#8243; header_font_size=&#8221;56px&#8221; max_width=&#8221;800px&#8221; custom_margin=&#8221;||17px|||&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Styrelsen<\/h6>\n<h1 class=\"top-heading\">Styrelsen<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; module_id=&#8221;board&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;e9afc0e7-c9bf-4a12-be49-63ddba231101&#8243; border_width_bottom=&#8221;0px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>Styrelsen<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial portrait_url=&#8221;https:\/\/idldiagnostics.com\/sv\/wp-content\/uploads\/2022\/05\/max-pihlqvist.jpg&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Chairman, <span>M.B.A.<\/span><\/h6>\n<h3>Max Pihlqvist<\/h3>\n<p>Max Pihlqvist har en masterexamen i f\u00f6retagsekonomi fr\u00e5n Lunds universitet och omfattande erfarenhet inom laboratorie- och diagnostikbranschen. Max Pihlqvist har tidigare erfarenhet fr\u00e5n IDL Biotech som styrelsemedlem under \u00e5ren 2017-2019.<\/p>\n<p>Idag arbetar Max som VD f\u00f6r Svenska Labex AB-koncernen med dotterbolag i Norge och Danmark och \u00e4r styrelseordf\u00f6rande f\u00f6r Labex Holding AB, Norsk Labex AS, Labex APS och Labex Reagens AB.<\/p>\n<p>Styrelseledamot sedan 2022<\/p>\n<p><strong>Innehav i IDL Diagnostics: 44 411 786 privat och genom bolag<\/strong><\/p>\n<p><span data-teams=\"true\">Beroende i f\u00f6rh\u00e5llande till en av f\u00f6retagets st\u00f6rre \u00e4gare, oberoende i f\u00f6rh\u00e5llande till bolaget och dess ledning.<\/span><\/p>\n<p>[\/et_pb_testimonial][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial portrait_url=&#8221;https:\/\/idldiagnostics.com\/sv\/wp-content\/uploads\/2021\/12\/Eva-Nordstrom.png&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Ph.D.<\/h6>\n<h3>Eva Nordstr\u00f6m<\/h3>\n<p>Eva har en doktorsexamen i immunologi under professor Erna M\u00f6ller vid Stockholms universitet och arbetar f\u00f6r n\u00e4rvarande som senior forskare p\u00e5 BioArctic AB. Hon har bred vetenskaplig erfarenhet fr\u00e5n utveckling av analyser, generering av hybridom och immunanalyser.<\/p>\n<p>Styrelseledamot sedan 2020<\/p>\n<p><strong>Innehav i IDL Diagnostics: 120 000 aktier.<\/strong><\/p>\n<p>Oberoende i f\u00f6rh\u00e5llande till bolaget och dess ledning samt i f\u00f6rh\u00e5llande till st\u00f6rre aktie\u00e4gare.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_testimonial][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial portrait_url=&#8221;https:\/\/idldiagnostics.com\/sv\/wp-content\/uploads\/2022\/10\/Agneta-Tufvesson-Alm.jpeg&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>B.S.Chem.<\/h6>\n<h3>Agneta Tufvesson Alm<\/h3>\n<p>Agneta Tufvesson Alm har mer \u00e4n 30 \u00e5rs erfarenhet av internationell f\u00f6rs\u00e4ljning och marknadsf\u00f6ring samt erfarenhet av direktf\u00f6rs\u00e4ljning i Norden och Storbritannien, region- och nyckelkundsansvar i Europa, Afrika och Mellan\u00f6stern. Agneta har arbetat med att bygga distributionsn\u00e4tverk, f\u00f6rhandla avtal och hantera f\u00f6rs\u00e4ljnings- och kundserviceteam. Hon arbetar f\u00f6r n\u00e4rvarande p\u00e5 Kemira Kemi AB och har tidigare haft roller p\u00e5 HemoCue AB, Thermo Quest och Kabi Pharmacia. Agneta har en kandidatexamen i kemi fr\u00e5n Lunds universitet.<\/p>\n<p>Styrelseledamot sedan 2022<\/p>\n<p><strong>Innehav i IDL Diagnostics: 20 000 aktier<\/strong><\/p>\n<p>Oberoende i f\u00f6rh\u00e5llande till bolaget och dess ledning samt i f\u00f6rh\u00e5llande till st\u00f6rre aktie\u00e4gare..<\/p>\n<ul><\/ul>\n<p>[\/et_pb_testimonial][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial portrait_url=&#8221;https:\/\/idldiagnostics.com\/sv\/wp-content\/uploads\/2021\/05\/per-anders-abrahamsson.jpg&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>MD, PhD, Professor i Urologisk onkologi<\/h6>\n<h3>Per-Anders Abrahamsson<\/h3>\n<p>Per-Anders Abrahamsson har en professur i Urologisk onkologi fr\u00e5n Lunds universitet.<\/p>\n<p>Andra nuvarande uppdrag: Styrelseledamot i Guldlyckan AB, Perituskliniken AB samt Medisport Holding AB.<\/p>\n<p>Tidigare uppdrag: Styrelseordf\u00f6rande och styrelseledamot i Uptake Bio AB samt tidigare styrelseledamot i AroCell AB (publ). Klinikchef i Malm\u00f6 och Lund i 20 \u00e5r samt Generalsekreterare f\u00f6r den v\u00e4rldsledande vetenskapliga organisationen European Association of Urology 2007\u20132015.<\/p>\n<p>Styrelseledamot sedan 2025<\/p>\n<p><strong>Innehav i IDL Diagnostics: Inga.<\/strong><\/p>\n<p>Oberoende i f\u00f6rh\u00e5llande till bolaget och dess ledning samt i f\u00f6rh\u00e5llande till st\u00f6rre aktie\u00e4gare.<\/p>\n<ul><\/ul>\n<p>[\/et_pb_testimonial][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; border_radii=&#8221;on|20px|20px|20px|20px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_testimonial portrait_url=&#8221;https:\/\/idldiagnostics.com\/sv\/wp-content\/uploads\/2023\/06\/Clas-Runnberg-e1687184831224.jpeg&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6 class=\"LC20lb MBeuO DKV0Md\">BSc<\/h6>\n<h3>Clas Runnberg<\/h3>\n<p>Clas \u00e4r f\u00f6r n\u00e4rvarande \u00e4ven styrelseordf\u00f6rande f\u00f6r Svenska Labex AB.<\/p>\n<p>Tidigare var han styrelseledamot i Adenovir Pharma AB, styrelseordf\u00f6rande i P.U.L.S. AB (nu Aqilion AB). Han har haft h\u00f6gre positioner inom marknadsf\u00f6ring p\u00e5 Viggo AB, Gambro AB och HemoCue AB samt inom f\u00f6retagsledning och strategisk aff\u00e4rsutveckling p\u00e5 Diatek Medical Technologies, CA, USA och Block Medical, CA, USA.<\/p>\n<p>Clas har en examen i marknadsekonomi fr\u00e5n Marknadsf\u00f6reningen\/Lunds universitet.<\/p>\n<p>Styrelseledamot sedan 2023<\/p>\n<p><strong>Innehav i IDL Diagnostics: 250 761 aktier<\/strong><\/p>\n<p><span data-teams=\"true\">Beroende i f\u00f6rh\u00e5llande till en av f\u00f6retagets st\u00f6rre \u00e4gare, oberoende i f\u00f6rh\u00e5llande till bolaget och dess ledning.<\/span><\/p>\n<ul><\/ul>\n<p>[\/et_pb_testimonial][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_module=&#8221;3466&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_menu menu_id=&#8221;29&#8243; disabled_on=&#8221;on|on|off&#8221; _builder_version=&#8221;4.18.0&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#F8F8F8&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_menu][et_pb_sidebar area=&#8221;et_pb_widget_area_2&#8243; disabled_on=&#8221;off|off|on&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;2efbbc8f-7ecb-4fe3-9956-d83a8a0e7a74&#8243; background_color=&#8221;#F8F8F8&#8243; global_colors_info=&#8221;{}&#8221;][\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; custom_padding_last_edited=&#8221;on|tablet&#8221; _builder_version=&#8221;4.9.4&#8243; _module_preset=&#8221;default&#8221; custom_margin_tablet=&#8221;||||false|false&#8221; custom_margin_phone=&#8221;&#8221; custom_margin_last_edited=&#8221;on|tablet&#8221; custom_padding_tablet=&#8221;||0px||false|false&#8221; custom_padding_phone=&#8221;&#8221; global_module=&#8221;2177&#8243; saved_tabs=&#8221;all&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row column_structure=&#8221;1_2,1_2&#8243; make_equal=&#8221;on&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;2000px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_2&#8243; module_class=&#8221;ds-vertical-align&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h6>Om oss<\/h6>\n<h3>Vi bist\u00e5r med kunskap till beslutsfattare<\/h3>\n<p>IDL Diagnostics \u00e4r ett svenskt diagnostikf\u00f6retag med visionen att f\u00f6rb\u00e4ttra \u00f6vervakningen av onkologiska och bakteriella sjukdomar. Vi har ett brett produktutbud av IVD-tester som levererar v\u00e4rdefull klinisk information f\u00f6r uppt\u00e4ckt av sjukdomar.<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/idldiagnostics.com\/sv\/om-arocell\/&#8221; button_text=&#8221;L\u00e4s mer om oss&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][\/et_pb_column][et_pb_column type=&#8221;1_2&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_image src=&#8221;https:\/\/idldiagnostics.com\/sv\/wp-content\/uploads\/2022\/10\/MG_7941-800.jpg&#8221; title_text=&#8221;MG_7941-600&#8243; src_tablet=&#8221;&#8221; src_phone=&#8221;https:\/\/idldiagnostics.com\/sv\/wp-content\/uploads\/2023\/08\/MG_7941-600.jpg&#8221; src_last_edited=&#8221;on|phone&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p><div class=\"et_pb_module dipi_breadcrumbs dipi_breadcrumbs_0\">\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t<div class=\"et_pb_module_inner\">\n\t\t\t\t\t<div class=\"dipi-breadcrumbs dipi-bc-left\">\n                <ul >\n                    \n                                                        <li  class=\"dipi-breadcrumb-item dipi-breadcrumb-home\">\n\n                                                    <a  href=\"https:\/\/idldiagnostics.com\/sv\">\n                                <span  content=\"Home\">\n                                                                        IDL Diagnostics                                <\/span>\n                            <\/a>\n\n                                                <meta itemprop=\"position\" content=\"1\"\/>                    <\/li>\n\n                    <li class=\"dipi-breadcrumb-separator\">\n                    <span class=\"et-pb-icon dipi-separator-icon\">&#x35;<\/span>\n                <\/li>                            \n                <\/ul>\n            <\/div>\n\t\t\t\t<\/div>\n\t\t\t<\/div>Styrelsen StyrelsenStyrelsenChairman, M.B.A. Max Pihlqvist Max Pihlqvist har en masterexamen i f\u00f6retagsekonomi fr\u00e5n Lunds universitet och omfattande erfarenhet inom laboratorie- och diagnostikbranschen. Max Pihlqvist har tidigare [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":2253,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"<!-- wp:divi\/placeholder \/-->","_et_gb_content_width":"","footnotes":""},"dipi_cpt_category":[],"class_list":["post-2824","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Styrelsen - IDL Diagnostics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/idldiagnostics.com\/sv\/investerare\/foretagsstyrning\/styrelsen\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Styrelsen - IDL Diagnostics\" \/>\n<meta property=\"og:description\" content=\"Styrelsen StyrelsenStyrelsenChairman, M.B.A. Max Pihlqvist Max Pihlqvist har en masterexamen i f\u00f6retagsekonomi fr\u00e5n Lunds universitet och omfattande erfarenhet inom laboratorie- och diagnostikbranschen. Max Pihlqvist har tidigare [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/idldiagnostics.com\/sv\/investerare\/foretagsstyrning\/styrelsen\/\" \/>\n<meta property=\"og:site_name\" content=\"IDL Diagnostics\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/arocell\" \/>\n<meta property=\"article:modified_time\" content=\"2026-02-24T13:40:01+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"4 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/sv\\\/investerare\\\/foretagsstyrning\\\/styrelsen\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/sv\\\/investerare\\\/foretagsstyrning\\\/styrelsen\\\/\",\"name\":\"Styrelsen - IDL Diagnostics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/arocell.com\\\/sv\\\/#website\"},\"datePublished\":\"2021-11-30T09:03:49+00:00\",\"dateModified\":\"2026-02-24T13:40:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/sv\\\/investerare\\\/foretagsstyrning\\\/styrelsen\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/idldiagnostics.com\\\/sv\\\/investerare\\\/foretagsstyrning\\\/styrelsen\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/idldiagnostics.com\\\/sv\\\/investerare\\\/foretagsstyrning\\\/styrelsen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/idldiagnostics.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Investerare\",\"item\":\"https:\\\/\\\/arocell.com\\\/sv\\\/investerare\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"F\u00f6retagsstyrning\",\"item\":\"https:\\\/\\\/arocell.com\\\/sv\\\/investerare\\\/foretagsstyrning\\\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"Styrelsen\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/arocell.com\\\/sv\\\/#website\",\"url\":\"https:\\\/\\\/arocell.com\\\/sv\\\/\",\"name\":\"IDL Diagnostics\",\"description\":\"Saving lives with diagnostics\",\"publisher\":{\"@id\":\"https:\\\/\\\/arocell.com\\\/sv\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/arocell.com\\\/sv\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/arocell.com\\\/sv\\\/#organization\",\"name\":\"IDL Diagnostics\",\"url\":\"https:\\\/\\\/arocell.com\\\/sv\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/arocell.com\\\/sv\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/idldiagnostics.com\\\/sv\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"contentUrl\":\"https:\\\/\\\/idldiagnostics.com\\\/sv\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/AroCell_logo.png\",\"width\":1713,\"height\":570,\"caption\":\"IDL Diagnostics\"},\"image\":{\"@id\":\"https:\\\/\\\/arocell.com\\\/sv\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/arocell\",\"https:\\\/\\\/linkedin.com\\\/company\\\/arocell\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Styrelsen - IDL Diagnostics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/idldiagnostics.com\/sv\/investerare\/foretagsstyrning\/styrelsen\/","og_locale":"sv_SE","og_type":"article","og_title":"Styrelsen - IDL Diagnostics","og_description":"Styrelsen StyrelsenStyrelsenChairman, M.B.A. Max Pihlqvist Max Pihlqvist har en masterexamen i f\u00f6retagsekonomi fr\u00e5n Lunds universitet och omfattande erfarenhet inom laboratorie- och diagnostikbranschen. Max Pihlqvist har tidigare [&hellip;]","og_url":"https:\/\/idldiagnostics.com\/sv\/investerare\/foretagsstyrning\/styrelsen\/","og_site_name":"IDL Diagnostics","article_publisher":"https:\/\/www.facebook.com\/arocell","article_modified_time":"2026-02-24T13:40:01+00:00","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"4 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/idldiagnostics.com\/sv\/investerare\/foretagsstyrning\/styrelsen\/","url":"https:\/\/idldiagnostics.com\/sv\/investerare\/foretagsstyrning\/styrelsen\/","name":"Styrelsen - IDL Diagnostics","isPartOf":{"@id":"https:\/\/arocell.com\/sv\/#website"},"datePublished":"2021-11-30T09:03:49+00:00","dateModified":"2026-02-24T13:40:01+00:00","breadcrumb":{"@id":"https:\/\/idldiagnostics.com\/sv\/investerare\/foretagsstyrning\/styrelsen\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/idldiagnostics.com\/sv\/investerare\/foretagsstyrning\/styrelsen\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/idldiagnostics.com\/sv\/investerare\/foretagsstyrning\/styrelsen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/idldiagnostics.com\/sv\/"},{"@type":"ListItem","position":2,"name":"Investerare","item":"https:\/\/arocell.com\/sv\/investerare\/"},{"@type":"ListItem","position":3,"name":"F\u00f6retagsstyrning","item":"https:\/\/arocell.com\/sv\/investerare\/foretagsstyrning\/"},{"@type":"ListItem","position":4,"name":"Styrelsen"}]},{"@type":"WebSite","@id":"https:\/\/arocell.com\/sv\/#website","url":"https:\/\/arocell.com\/sv\/","name":"IDL Diagnostics","description":"Saving lives with diagnostics","publisher":{"@id":"https:\/\/arocell.com\/sv\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/arocell.com\/sv\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/arocell.com\/sv\/#organization","name":"IDL Diagnostics","url":"https:\/\/arocell.com\/sv\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/arocell.com\/sv\/#\/schema\/logo\/image\/","url":"https:\/\/idldiagnostics.com\/sv\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","contentUrl":"https:\/\/idldiagnostics.com\/sv\/wp-content\/uploads\/2022\/10\/AroCell_logo.png","width":1713,"height":570,"caption":"IDL Diagnostics"},"image":{"@id":"https:\/\/arocell.com\/sv\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/arocell","https:\/\/linkedin.com\/company\/arocell"]}]}},"_links":{"self":[{"href":"https:\/\/idldiagnostics.com\/sv\/wp-json\/wp\/v2\/pages\/2824","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/idldiagnostics.com\/sv\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/idldiagnostics.com\/sv\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/sv\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/sv\/wp-json\/wp\/v2\/comments?post=2824"}],"version-history":[{"count":1,"href":"https:\/\/idldiagnostics.com\/sv\/wp-json\/wp\/v2\/pages\/2824\/revisions"}],"predecessor-version":[{"id":5444,"href":"https:\/\/idldiagnostics.com\/sv\/wp-json\/wp\/v2\/pages\/2824\/revisions\/5444"}],"up":[{"embeddable":true,"href":"https:\/\/idldiagnostics.com\/sv\/wp-json\/wp\/v2\/pages\/2253"}],"wp:attachment":[{"href":"https:\/\/idldiagnostics.com\/sv\/wp-json\/wp\/v2\/media?parent=2824"}],"wp:term":[{"taxonomy":"dipi_cpt_category","embeddable":true,"href":"https:\/\/idldiagnostics.com\/sv\/wp-json\/wp\/v2\/dipi_cpt_category?post=2824"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}